Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hostelworld shares tank as H1 bookings fail to grow

(Sharecast News) - Hostelworld said on Thursday it expects to hit market forecasts with its full-year profits, though shares fell sharply after the company reported flat bookings despite a big increase in marketing costs. The social media-powered online travel agent said net revenues totalled €46.7m in the six months to 30 June, in line with expectations but unchanged over last year.

Net bookings were also flat at 3.7m, while the net average booking value fell 1% to €13.40.

Nevertheless, the company did said that booking volumes and average booking values increased across all key regions in June, with strong demand for intra-European travel driven by modest bed price deflation.

Adjusted EBITDA fell to €7.3m from €9.6m the year before, with direct marketing totalling 51% of revenues, up from 45% previously. However, chief executive Gary Morrison said this was "primarily driven by cost inflation in the first few months (which has since moderated) and the growth of paid channels as a proportion of total web channels".

Hostelworld said it still expects to meet the adjusted EBITDA consensus forecast of €19.9m for the full year, compared with €21.8m in 2024.

"Although trading in the first half showed mixed results across regions and channels, we are encouraged by the positive trends observed in June," said Morrison.

The shares were down more than 12% at 123.9p by the midday mark.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.